MOUNTAIN VIEW, Calif. — IRIDEX Corporation, headquartered in Mountain View, California, and Imperial College Healthcare NHS Trust in London, today announced the first patient enrollment in a collaborative medical research study and registry evaluating the treatment of glaucoma with MicroPulse® Transscleral Laser Therapy (TLT) using Iridex’ Cyclo G6® Laser and...
research News
Ireland’s relative lack of immigration and pure gene pool has made its people a great test study for degenerative brain disorders. So says consultant neurologist at Beaumont Hospital Professor Orla Haridman, who is also clinical professor of neurology at Trinity College Dublin. The professor is concentrating on research on Motor...
GOTHENBURG, SWEDEN – IRLAB Therapeutics, a company discovering and developing novel treatments for Parkinson’s disease, today announced that the US FDA has granted an end-of-Phase 2 meeting for the mesdopetam program on February 20, 2024. “The end-of-Phase 2 meeting is an important milestone for the mesdopetam program. The further development...
Barcelona, Spain – Fibrosis is associated with various chronic and life-threatening conditions, including pulmonary fibrosis, liver cirrhosis, kidney disease, and cardiovascular diseases, among others. These conditions collectively contribute to a substantial portion of mortality in developed countries, making fibrotic diseases a critical health problem requiring attention, research, and innovative approaches...
PITTSBURGH, PA – Common neuropsychiatric symptoms that doctors see in Alzheimer’s disease patients originate from brain inflammation rather than amyloid and tau proteins, report University of Pittsburgh School of Medicine researchers today in. The finding strengthens mounting evidence for the role of neuroinflammation in Alzheimer’s progression and suggests new pathways...
Sharjah, United Arab Emirates – Anti-N-methyl-d-aspartate (Anti-NMDA) receptor encephalitis is an acute autoimmune disorder that develops both neurological symptoms and psychiatric symptoms, including hallucination, cognitive disturbance, epilepsy, movement disorder and impaired consciousness. This disease may be misdiagnosed at the early stage as a psychosis disease because of primary psychiatric symptoms....
Amsterdam, The Netherlands – There are several risk factors for the development of Alzheimer’s disease and vascular dementia. Based on an increasing number of studies linking these risk factors with Vitamin D deficiency, an article in the current issue of the Journal of Alzheimer’s Disease (May 2009) by William B....
Isernia, Italy – A study conducted by the Research Unit of Epidemiology and Prevention at the I.R.C.C.S. Neuromed in Pozzilli, in collaboration with the LUM University of Casamassima, shows that high consumption of ultra-processed foods is associated with the acceleration of biological aging, regardless of the nutritional quality of the...
São Paulo, Brazil – In a study with 49 participants, researchers at the State University of Campinas found that daily consumption of a dietary supplement containing 15 g of the substance for five weeks improved glucose metabolism even after meals. The skin or peel of the Jaboticaba berry (Plinia jaboticaba),...
The Food and Drug Administration (FDA) has updated the fact sheet for the Janssen COVID-19 vaccine to include information related to the potential increased risk of developing Guillain-Barré syndrome. Guillain-Barré syndrome is a rare neurological disorder in which the body’s immune system damages nerve cells causing muscle weakness and sometimes...